Alexandre Harari
Tumor immunology


Undergraduate, University of Lausanne, Switzerland

PhD, University Hospital of Lausanne (CHUV), Switzerland

The principal objective of my work is improve our understanding of two distinct components of the dynamic between tumors and T cells: what are tumor rejection antigens and what are the T-cell features associated with better efficacy, both key questions in the development of novel personalized therapies.

Ludwig Institute for Cancer Research, Lausanne
Agora Research Center
Rue du Bugnon 25A, CH-1005 Lausanne

T (41) 21 545 10 77
F (41) 21 692 59 95


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?